The Mumbai-based firm along with many other companies had received communication from EMA for suspension of Trimetazidine MR 35 mg and Cefpodoxime 200 mg tablets in January 2015.
The post Lupin submits fresh studies for two generic drugs suspended by EMA appeared first on Firstpost.